Study with dapagliflozin

Trial Identifier:	D1690R00030
Sponsor:	AstraZeneca
NCTID::	NCT02971618
Start Date:	February 2017
Primary Completion Date:	August 2018
Study Completion Date:	August 2018
Condition:	Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Russia	Saint Petersburg, Russia
Russia, Russia	Moscow, Russia, Russia

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.